In the Globe and Mail on September 11, 2014, Dr. Jay Wunder explains how far we've come in advances in sarcoma research and treatment since Terry Fox died over three decades ago. Today, the cure rate’s almost up to 80 per cent in younger patients.
Read the full story here.
Dr. Wunder is an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, and Surgeon-in-Chief at Mount Sinai Hospital''s Christopher Sharp Centre for Surgery and Oncology. He specializes in bone and soft tissue sarcomas, including osteosarcoma, a form of musculoskeletal cancer.